T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Las Vegas Sands
LVS
$29.6B
| $1.38B | 0.19% |
23,294,403
-2,739,109
| -11% | -$170M |
|
127
CoStar Group
CSGP
$12.6B
| $1.36B | 0.19% |
24,527,240
+59,250
| +0.2% | +$3.03M |
|
128
PepsiCo
PEP
$189B
| $1.35B | 0.19% |
10,269,040
-1,707,413
| -14% | -$219M |
|
129
Vail Resorts
MTN
$5.26B
| $1.34B | 0.19% |
6,008,195
-706,571
| -11% | -$157M |
|
130
Kimberly-Clark
KMB
$36.1B
| $1.31B | 0.18% |
9,837,630
-728,485
| -7% | -$93.9M |
|
131
Citigroup
C
$228B
| $1.31B | 0.18% |
18,636,092
-255,339
| -1% | -$17.1M |
|
132
Yum! Brands
YUM
$39.5B
| $1.3B | 0.18% |
11,783,686
-587,214
| -5% | -$61M |
|
133
Synopsys
SNPS
$78.7B
| $1.3B | 0.18% |
10,074,160
-439,822
| -4% | -$52.9M |
|
134
American Tower
AMT
$79B
| $1.29B | 0.18% |
6,325,047
-780,705
| -11% | -$157M |
|
135
Applied Materials
AMAT
$417B
| $1.27B | 0.18% |
28,351,337
+7,230,052
| +34% | +$304M |
|
|
CTLT
136
DELISTED
CATALENT, INC.
CTLT
| $1.24B | 0.17% |
22,898,472
-194,246
| -0.8% | -$8.89M |
|
137
United Parcel Service
UPS
$88.8B
| $1.22B | 0.17% |
11,788,515
+3,155,121
| +37% | +$328M |
|
138
AT&T
T
$168B
| $1.19B | 0.17% |
47,174,152
+937,943
| +2% | +$22.5M |
|
139
Crown Castle
CCI
$31.3B
| $1.19B | 0.17% |
9,094,370
-449,907
| -5% | -$57.9M |
|
140
Micron Technology
MU
$981B
| $1.14B | 0.16% |
29,459,631
+10,672,909
| +57% | +$407M |
|
141
Bright Horizons
BFAM
$3.76B
| $1.13B | 0.16% |
7,522,558
+519,883
| +7% | +$69.7M |
|
142
West Pharmaceutical
WST
$24.7B
| $1.11B | 0.16% |
8,900,778
+130,672
| +1% | +$15.4M |
|
143
Berkshire Hathaway Class B
BRK.B
$1.11T
| $1.11B | 0.16% |
5,217,971
+169,467
| +3% | +$35.1M |
|
144
Wynn Resorts
WYNN
$10.8B
| $1.1B | 0.15% |
8,857,209
+801,270
| +10% | +$103M |
|
145
US Bancorp
USB
$100B
| $1.1B | 0.15% |
20,957,923
-1,650,025
| -7% | -$85M |
|
146
Equifax
EFX
$21.4B
| $1.1B | 0.15% |
8,106,774
-2,872,345
| -26% | -$360M |
|
147
Broadcom
AVGO
$1.98T
| $1.1B | 0.15% |
38,073,140
-9,448,860
| -20% | -$275M |
|
148
Eversource Energy
ES
$26.8B
| $1.09B | 0.15% |
14,429,007
+7,496,179
| +108% | +$549M |
|
149
Gartner
IT
$11.8B
| $1.08B | 0.15% |
6,741,402
-277,422
| -4% | -$43.4M |
|
150
Booz Allen Hamilton
BAH
$9.45B
| $1.07B | 0.15% |
16,223,011
+3,214,910
| +25% | +$198M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.